Multiple Sclerosis Trial, Recruiting NCT06410261 Sponsor: University of Illinois at Chicago Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06410261
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Multiple Sclerosis (MS)
  • You are 18 years of age or older
  • You have not had an MS relapse (flare-up) in the last 30 days
  • You use a wheelchair as your main way of getting around in the community
  • You are able to walk at least 50 feet (about 65 steps) with the help of a walking aid
  • You are considered low risk for physical activity, meaning you answered "yes" to no more than one question on a standard health screening questionnaire called the PAR-Q (confirm with trial site)
  • You are willing to complete all required assessments and be randomly assigned to a treatment group

Who may not be able to join:

  • You have not been diagnosed with MS
  • You are under 18 years of age
  • You have had an MS relapse (flare-up) within the last 30 days
  • You do not use a wheelchair as your main way of getting around
  • You are not able to walk at least 50 feet (about 65 steps) even with a walking aid
  • You are considered higher risk for physical activity, meaning you answered "yes" to more than one question on the PAR-Q health screening questionnaire (confirm with trial site)
  • You are not willing to complete all required tests and assessments or be randomly assigned to a treatment group

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Enrico Benedetti, MD, University of Illinois at Chicago

Phone: 312-355-1493

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
ClinicalTrials.gov
Start date
29 April 2024
Est. completion
31 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Physical Function; Walking Speed; Lower-Extremity Function; Walking Endurance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov